Literature DB >> 25391614

Hepatopulmonary syndrome associated with visceral leishmaniasis.

Nihal Martis1, Christelle Pomares, Pierre Yves Jeandel, Thierry Lazure, Pierre Marty, Eric Rosenthal.   

Abstract

Leishmaniasis caused by Leishmania infantum is endemic in the Mediterranean region. Its visceral form can present a diagnostic challenge owing to the disease's wide spectrum of clinical presentations. We describe the very atypical case of a 66-year-old male Caucasian patient with hepatopulmonary syndrome and an exceptionally rare expression of visceral leishmaniasis in a disseminated form with mucocutaneous involvement presenting as an autoimmune systemic disease.

Entities:  

Mesh：

Year:  2015        PMID： 25391614     DOI： 10.1007/s12026-014-8592-2

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


  11 in total

1.  Portal hypertension with visceral leishmaniasis.

Authors:  Rajniti Prasad; Utpal Kant Singh; O P Mishra; B P Jaiswal; Sunil Muthusami
Journal:  Indian Pediatr       Date:  2010-03-15       Impact factor: 1.411

2.  'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

Authors:  N Bourgeois; P Bastien; J Reynes; A Makinson; I Rouanet; L Lachaud
Journal:  HIV Med       Date:  2010-11       Impact factor: 3.180

3.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Cryoglobulinemic purpura in visceral leishmaniasis.

Authors:  Evangelos Rizos; George Dimos; Evangelos N Liberopoulos; Moses S Elisaf; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

Review 5.  Molecular mimicry between host and pathogen: examples from parasites and implication.

Authors:  M Abu-Shakra; D Buskila; Y Shoenfeld
Journal:  Immunol Lett       Date:  1999-04-01       Impact factor: 3.685

Review 6.  Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats.

Authors:  Christian Bogdan
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

7.  Visceral leishmaniasis and HIV-1 co-infection in southern France.

Authors:  E Rosenthal; P Marty; I Poizot-Martin; J Reynes; F Pratlong; A Lafeuillade; D Jaubert; O Boulat; J Dereure; F Gambarelli
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Mar-Apr       Impact factor: 2.184

8.  Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis.

Authors:  Rita de Cassia dos Santos Ferreira; Ana Lúcia Coutinho Domingues; Brivaldo Markman Filho; Flávio Henrique Amaral Pires Veras; Luiz José de Barros Batista; Eolo Santana Albuquerque Filho
Journal:  Acta Trop       Date:  2009-03-25       Impact factor: 3.112

9.  Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients.

Authors:  Matteo Vassallo; Olivier Moranne; Damien Ambrosetti; Pierre-Yves Jeandel; Christelle Pomares; Elisabeth Cassuto; Annick Boscagli; Guillaume Giraud; Nathalie Montagne; Chiara Dentone; Ilaria Demacina; Barbara Villaggio; Giovanni Secondo; Giuseppe Ferrea; Corinne Passeron; Laurence Saudes; Regis Kaphan; Pierre Marty; Eric Rosenthal
Journal:  BMC Infect Dis       Date:  2014-10-30       Impact factor: 3.090

Review 10.  Epidemiology of visceral leishmaniasis.

Authors:  Paul D Ready
Journal:  Clin Epidemiol       Date:  2014-05-03       Impact factor: 4.790
View more
  1 in total

1.  Natural transmission of Leishmania infantum through experimentally infected Phlebotomus perniciosus highlights the virulence of Leishmania parasites circulating in the human visceral leishmaniasis outbreak in Madrid, Spain.

Authors:  Inés Martín-Martín; Maribel Jiménez; Estela González; César Eguiluz; Ricardo Molina
Journal:  Vet Res       Date:  2015-12-09       Impact factor: 3.683
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.